D-0750-2021 Class II Terminated
FDA drug recall D-0750-2021 was initiated by Dr. Reddy's Laboratories, Inc. on Jul 19, 2021 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specification: Some tablets are shaved The recall status is terminated (terminated Dec 21, 2022). Affected quantity: 37560 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 25, 2021
- Initiation Date
- Jul 19, 2021
- Termination Date
- Dec 21, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 37560 bottles
Product description
Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA, NDC 55111-180-15.
Reason for recall
Failed Tablet/Capsule Specification: Some tablets are shaved
Distribution pattern
Nationwide within the United States
Code information
Lot #: T2000471, exp date 09/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0750-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026